CDEK by Data4ThePeople
Drugs
Search by NameFDA Approval TrendsAdvanced SearchFDA Approved Drugs
Organizations
Search by NameOrganization TrendsAdvanced Search
IndicationsMechanismsTrialsFDA Approvals
About
About CDEKGlossaryAdvanced Search GuideSearch by Name
Drugs
Search by NameFDA Approval TrendsAdvanced SearchFDA Approved Drugs
Organizations
Search by NameOrganization TrendsAdvanced Search
IndicationsMechanismsTrialsFDA Approvals
About
About CDEKGlossaryAdvanced Search GuideSearch by Name
← All indications

Acalculous Cholecystitis

Inflammation of the GALLBLADDER wall in the absence of GALLSTONES.

Drugs by status

Other trials (2)

  • propofol
  • remimazolam

Organizations

Organization Involved with Phase 4 Indications (6)

  • Pfizer
  • Wyeth
  • Hamad Medical Corporation
  • Hospital Italiano de Buenos Aires
  • Konya Training and Research Hospital
  • University of Texas, San Antonio

Organization Involved with Phase 3 Indications (7)

  • Peninsula Pharmaceuticals
  • Bayer
  • University of Heidelberg
  • Karolinska Institute
  • Ewha Womans University
  • Johnson and Johnson
  • University of Picardie Jules Verne

Organization Involved with Phase 1 Indications (2)

  • Ohio State University
  • Stryker

Organization Involved with Other Experimental Indications (5)

  • Cedars-Sinai Medical Center
  • Indiana University
  • Maimonides Medical Center
  • University of Warwick
  • Society of American Gastrointestinal and Endoscopic Surgeons

CDEK

The Clinical Drug Experience Knowledgebase — tracking drugs, sponsoring organizations, and clinical trials from first-in-human testing through approval.

Browse

  • Drugs
  • Organizations
  • Trials

About

  • About CDEK
  • Glossary

Built and maintained by Data4ThePeople.

YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED "AS IS", WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.